Alnylam Pharmaceuticals
ALNY
#601
Rank
โ‚น2.833 T
Marketcap
โ‚น21,889
Share price
-5.28%
Change (1 day)
71.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company